Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 17 ... acute myeloid leukemia, and 21 had acute lymphoid leukemia. Stem cell sources included bonemarrow in 38, peripheral blood in 4, and cord blood (CB) in 14. Four patients died ... outcomes in children with acute leukemia who received allogeneic hematopoietic stem cell transplantation (HCT) using unrelated donor. Fifty-six children in complete remission (CR) received HCT ...
2009 NOV 23 ... boy affected with this disease. ALD is currently treated with allogeneic bone marrow transplantation when there is an appropriate donor. Even so, the graft sometimes does not take and there ...
2009 NOV 23 ... human antibodies and practiced oncology with a specialty in hematologic malignancies and bone marrow transplantation. Dr. Dessain is also involved in the Hematology/Oncology fellowship program at the ...
2009 NOV 23 ... contact A. Gallamini, Az Ospedaliera S Croce e Carle, Hematology Dept. of and Bone Marrow Transplantation Unit, via M Coppino, 26, 12100 Cuneo, Italy. Publisher contact information ...
2009 NOV 16 ... "Little is known about the contribution of bonemarrow-derived progenitor cells (BMPCs) in the regulation endothelial barrier function ... cells induced Rac1 and Cdc42 activation and AJ assembly in endothelial cells. However, transplantation of BMPCs isolated from sphingosine kinase-1-null mice (SPHK1(-/-)), having impaired S1P ...
2009 NOV 23 ... with tacrolimus monotherapy during Era III (7/01-11/08) During Era II/III, donor bonemarrow was given (n =- 79) intestine was ex vivo Irradiated (n = 44), and ... To assess the evolution of visceral transplantation In the milieu Of surgical technical modifications. new immunosuppressive protocols, and ...
2009 NOV 23 ... 10). Heterotopic osteomyocutaneous flap transplantation was performed 4 to 6 weeks after bone marrow transplantation. Mixed chimerism was initially achieved in almost all recipients, but long-term ...
2009 NOV 23 ... as paneth cells." "NOD2 has not been studied in experimental allogeneic bone marrow transplantation (allo-BMT). Using chimeric recipients with NOD2(-/-) hematopoietic cells, we demonstrate ...
2009 NOV 16 ... obliterans organizing pneumonia and nephrotic syndrome 5 months after allogeneic bone marrow transplantation from an unrelated donor for acute lymphoblastic leukemia," scientists in Chiba, Japan ...
2009 NOV 16 ... wild-type counterparts. Finally, analysis of Cd81(-/-) B cells that were generated by bone marrow transplantation into Rag1(-/-) mice confirmed that the hyperactive phenotype is not dependent on the ...
2009 NOV 16 ... For additional information, contact B. Cappelli, Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy. Publisher contact ...
2009 NOV 23 ... lymphocyte infusion or other interventions were used for mixed donor chimerism (MDC). Bonemarrow (BM) and/or peripheral blood (PB) samples were obtained at 30 days, 100 days, 180 ... analyzed the kinetics of CD3 chimerism in 120 consecutive allogeneic hematopoietic cell transplantation (HCT) recipients receiving alemtuzumab-based conditioning. Fifty-two received ...
2009 NOV 28 ... the earlier experiments to reprogram the stem cells to produce IDUA. They then performed bone marrow transplantation on the MPS I mice with the reprogrammed cells. The developing red blood cells in these ...
Subject: Cincinnati Children's Hospital Medical Center
2009 NOV 16 ... today in Herzliya entitled Umbilical Cord Blood: An Alternative for Bone Marrow Transplantation in Adults, bone marrow transplantation experts ...
2009 NOV 16 ... At a symposium today in Herzliya entitled Umbilical Cord Blood: An Alternative for Bone Marrow Transplantation in Adults, bone marrow transplantation experts ...
2009 NOV 16 ... AML (FAB M5, complex karyotype)." "Fourteen months after successful bone marrow transplantation, she presented with asymptomatic masses in both breasts. Ultrasound-guided biopsy was ...
2009 NOV 23 ... (ASCT). In the context of ASCT, achieving CR (negative immunofixation and normal bonemarrow) or at least very good partial response is associated with longer ... could be shown only after introduction of high-dose therapy plus autologous stem cell transplantation (ASCT). In the context of ASCT, achieving CR (negative immunofixation and normal bone ...
2009 NOV 23 ... class I major histocompatibility complex (MHC) antigens. While radiation and syngeneic bone marrow transplantation (BMT) reduced tumor growth (P < 0.001), allogeneic BMT further impaired subcutaneous ...
2009 NOV 16 ... the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bonemarrow, and the immunologic, hemostatic, and vascular systems, by promoting research, ... of Medicine and Director, Division of Hematology, Epstein Chair in Cell Therapy and Transplantation, University of Toronto, and Director, Cell Therapy Program, Princess Margaret Hospital, ...
